INAF Overview
INAF
Indofarma Tbk.
126
BUMNIDXBUMN20
YTD0.00%
1Y0.00%
52W Low52W High
126Current: 126126
Foreign Investor Activity
Company Profile vs Peers
Key Highlights
ROE 33.1% — strong capital efficiency
Operating at a net loss
D/E -0.95x — low leverage
State-owned enterprise (BUMN)
Company Info
SectorKesehatan
Sub-sectorFarmasi & Riset Kesehatan
IndustryFarmasi
Sub-industryFarmasi
Listing BoardPemantauan Khusus
Listed2001-04-17
AddressJl. Indofarma No. 1, Cikarang Barat, Bekasi, 17530
WebsiteVisit
Major Shareholders
PT Bio Farma (Persero)
PT Asabri (Persero) - Dapen TNI
Negara Republik Indonesia
Saham Treasury
Masyarakat Warkat
Masyarakat Non Warkat
Didi Agus Mintadi
Sahat SIhombing
Andi Prazos
Score Summary
Weak · 38%Overall Score
value
100%
competitive
39%
future
0%
financials
27%
dividend
0%
Technical Rating
Strong SellBased on 26 indicators
1 Buy10 Neutral15 Sell
Key Statistics
Valuation
Market Cap
390.5B
P/E Ratio
-0.56
P/B Ratio
-0.44
P/S Ratio
1.89
EV/EBITDA
-5.37
Profitability
ROE
+33.12%
ROA
-22.22%
Gross Margin
-20.10%
Op. Margin
-117.86%
Net Margin
-143.08%
Growth & Health
Rev Growth
—
EPS Growth
—
Div Yield
—
Debt/Equity
-0.95
Current Ratio
0.13
EPS
-226.69
Valuation vs Peers
How Indofarma Tbk. compares to 0 peers in Farmasi & Riset Kesehatan.
P/E Ratio
-0.56x
P/B Ratio
-0.44x
P/S Ratio
1.89x
EV/EBITDA
-5.37x
Intrinsic Value
Intrinsic value data is not available for INAF.
Valuation & Metrics
Ownership Structure
Peer Comparison
Financial Statements
Income Flow — 2025-09-30
Revenue
66.7B
COGS
-68.3B
Gross Profit
-1.6B
OpEx
-70.1B
Op. Income
-71.7B
Tax & Other
-11.8B
Net Income
-83.5B
Financial Statements
| Metric | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Revenue | 66.7B | 30.3B |
| Gross Profit | -1.6B | -4.4B |
| Operating Income | -71.7B | -18.6B |
| Net Income | -83.5B | -18.4B |
| EBITDA | -73.2B | -17.0B |
| Total Assets | 581.6B | 559.6B |
| Total Equity | -890.9B | -807.4B |
| Total Debt | 845.7B | 653.8B |
| Operating Cash Flow | — | — |
| Free Cash Flow | -162.2B | 1.6B |
Dividend History
TTM Div Yield
—
Payout Ratio
—
EPS
-226,69
Corporate Actions
Insider Trades
Broker Flow
Research Notes
Latest News
No recent news for INAF.
Management
Board of Directors
SAHAT SIHOMBINGDIREKTUR UTAMA
ANDI PRAZOSDIREKTUR
Board of Commissioners
Didi Agus MintadiKOMISARIS